Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.2B |
| 2 |
Tesla
TSLA
|
+$935M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$585M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$515M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$495M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$935M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$452M |
| 3 |
Amazon
AMZN
|
+$423M |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$422M |
| 5 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$316M |
Sector Composition
| 1 | Technology | 9.74% |
| 2 | Consumer Discretionary | 8.86% |
| 3 | Financials | 7.26% |
| 4 | Communication Services | 5.03% |
| 5 | Healthcare | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4826
Alight
ALIT
$1.9B
| $97K | ﹤0.01% |
13,255
-15,462
| -54% | -$113K |
|
4827
Allbirds
BIRD
$49.8M
| $97K | ﹤0.01% |
1,591
-12,500
| -89% | -$762K |
|
|
AWF
4828
AllianceBernstein Global High Income Fund
AWF
$971M
| $96K | ﹤0.01% |
+10,824
| New | +$96K |
|
4829
Shuttle Pharmaceuticals
SHPH
$3.75M
| $96K | ﹤0.01% |
+105
| New | +$96K |
|
4830
indie Semiconductor
INDI
$764M
| $95K | ﹤0.01% |
13,027
+2,581
| +25% | +$18.8K |
|
4831
Janus International
JBI
$1.43B
| $95K | ﹤0.01% |
+10,658
| New | +$95K |
|
4832
Pitney Bowes
PBI
$1.96B
| $95K | ﹤0.01% |
40,856
-175,165
| -81% | -$407K |
|
|
PAYA
4833
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $95K | ﹤0.01% |
15,476
+2,929
| +23% | +$18K |
|
4834
ImmunityBio
IBRX
$2.56B
| $94K | ﹤0.01% |
18,874
-23,731
| -56% | -$118K |
|
4835
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$676M
| $94K | ﹤0.01% |
671
+53
| +9% | +$7.43K |
|
4836
Ocular Therapeutix
OCUL
$2.16B
| $94K | ﹤0.01% |
22,658
-24,286
| -52% | -$101K |
|
4837
AXT Inc
AXTI
$178M
| $93K | ﹤0.01% |
+13,912
| New | +$93K |
|
|
PRT
4838
PermRock Royalty Trust Unit
PRT
$46.1M
| $93K | ﹤0.01% |
+12,905
| New | +$93K |
|
4839
Personalis
PSNL
$521M
| $93K | ﹤0.01% |
31,464
-36,782
| -54% | -$109K |
|
4840
Sonder
SOND
$22.5M
| $93K | ﹤0.01% |
2,814
+1,968
| +233% | +$65K |
|
4841
Zynex
ZYXI
$44.8M
| $93K | ﹤0.01% |
+10,232
| New | +$93K |
|
|
APGN
4842
DELISTED
Apexigen, Inc. Common Stock
APGN
| $93K | ﹤0.01% |
34,421
-42,929
| -55% | -$116K |
|
4843
NeoVolta
NEOV
$175M
| $92K | ﹤0.01% |
+18,253
| New | +$92K |
|
|
AMTD
4844
AMTD IDEA Group
AMTD
$103M
| $91K | ﹤0.01% |
+12,713
| New | +$91K |
|
4845
Liquidia Corp
LQDA
$2.19B
| $91K | ﹤0.01% |
+16,745
| New | +$91K |
|
4846
Invesco California Value Municipal Income Trust
VCV
$508M
| $91K | ﹤0.01% |
+10,171
| New | +$91K |
|
4847
Telefônica Brasil
VIV
$20.3B
| $91K | ﹤0.01% |
+12,082
| New | +$91K |
|
4848
CollPlant Biotechnologies
CLGN
$34.1M
| $90K | ﹤0.01% |
+13,265
| New | +$90K |
|
4849
GDEV Inc. Warrant
GDEVW
$356K
| $90K | ﹤0.01% |
126,820
| – | – |
|
4850
Immunovant
IMVT
$2.74B
| $90K | ﹤0.01% |
+16,106
| New | +$90K |
|